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Aims
Microvascular perfusion abnormalities in hypertrophic
cardiomyopathy (HCM) are important markers of prog-
nosis and may act as a trigger for arrhythmic events. Mag-
netic resonance first pass perfusion is a validated non-
invasive imaging tool for the assessment of microvascular
dysfunction by the quantification of myocardial perfusion
reserve indices (MPRI). There are limited data available
for the intrastudy and interstudy reproducibility of quan-
tification using commercially available software. We
sought to determine the intrastudy variability for MPRI in
patients with HCM.
Methods
We performed adenosine first-pass stress and rest per-
fusion on 26 patients with HCM on a 1.5 T Siemens
Avanto scanner at our institution. A 3 slice hybrid-EPI
sequence was used (TR 5.8 ms, 30°, ETL 4, 1860 Hz/
pixel,2.8 × 2.8 × 8 mm voxels over typically 360 × 270 mm
FOV (adapted per patient) at TI = 110–140 ms after BIR-4
saturation for each of the 3 fat-suppressed slices per cycle,
using TSENSE (R2, coil profiles average 8)). Gadolinium
dose used for first-pass was 0.1 mmol/kg injected as a
bolus at 7 mL/sec followed by a 15 mL saline flush
through a power injector. In the 1st 50 ms of the perfusion
scan, a low resolution FLASH image was acquired to deter-
mine the blood signal (arterial input function) in order to
determine the MPRI. A single observer, blinded to patient
clinical data, analyzed each perfusion study at two sepa-
rate time points to reduce bias. For perfusion analysis, the
epi and endocardium was manually delineated and the
myocardium was divided into 16 segments according to
the ACC/AHA model. Each segment was subdivided into
endocardial and epicardial segments and MPRI were cal-
culated using customized software (CMRTools, Cardio-
vascular Imaging Solutions, London, UK).
Results
Coefficients of variation were calculated as the standard
deviation of the differences between the two measure-
ments divided by the mean value, and comparison of val-
ues was calculated using a Bland-Altman plot (Figure 1).
In total, 825 segments were compared for agreement and
sub analysis was performed to determine if greater intras-
tudy variability occurred in different segments. In general
there was a good agreement between all segments
between analysis dates, with a coefficient of variability of
34% for all segments. There was no significant difference
in agreement on a segment by segment basis. Agreement
was greater for MPRI values which are considered abnor-
mal (<2.5) and this may be relevant for analysis of abnor-
mal perfusion studies. See table in Figure 2.
Conclusion
Microvascular perfusion abnormalities are common in
HCM and may represent a novel therapeutic target. The
spatial resolution on CMR perfusion is such that changes
in perfusion values over time or in response to therapies
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power any study assessing changes in MPRI over time, it is
important to know the intrastudy and interstudy variabil-
ity of the technique. We have determined the intrastudy
variability for myocardial perfusion reserve index analysis
patients with HCM undergoing adenosine stress MR per-
fusion, which an important step in potentially following
values over time.
Bland Altman plot of intrastudy agreement in MPRI analysis for 825 myocardial segments in hypertrophic cardiomyopathyFigure 1
Bland Altman plot of intrastudy agreement in MPRI analysis for 825 myocardial segments in hypertrophic cardiomyopathy.Page 2 of 3
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Table of segmental MPRI variability for 825 myocardial segments in hypertrophic cardiomyopathyFigure 2
Table of segmental MPRI variability for 825 myocardial segments in hypertrophic cardiomyopathy.
